SPOTLIGHT -
EP. 1: Understanding the Recent WHO MDS Classification Updates
EP. 2: Accurate Risk Assessment in MDS
EP. 3: MDS: When the Prognostic Models Fall Short
EP. 4: Quality of Life in Transfusion-Dependent MDS
EP. 5: Monitoring for Iron Overload in Transfusion-Dependent MDS
EP. 6: Evidence With Iron Chelation Therapy in MDS
EP. 7: Patient Selection Considerations With Iron Chelation Therapy in MDS
EP. 8: Considering Lenalidomide in Non-Del 5q MDS
EP. 9: Sequencing Strategies in Low-Risk MDS
EP. 10: Hypomethylating Agents in Low-Risk MDS
EP. 11: Emerging Therapies in Low-Risk MDS
EP. 12: Transplantation Candidacy in MDS
EP. 13: MDS: Before and After Stem Cell Transplantation
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
